Literature DB >> 24439864

Cilostazol enhances mobilization and proliferation of endothelial progenitor cells and collateral formation by modifying vasculo-angiogenic biomarkers in peripheral arterial disease.

Ting-Hsing Chao1, Shih-Ya Tseng2, I-Chih Chen3, Yi-Shan Tsai4, Yao-Yi Huang5, Ping-Yen Liu6, Horng-Yih Ou6, Yi-Heng Li6, Hua-Lin Wu7, Chung-Lung Cho2, Liang-Miin Tsai6, Jyh-Hong Chen6.   

Abstract

Entities:  

Keywords:  Angiogenesis; Biological markers; Cilostazol; Peripheral arterial disease; Progenitor cells

Mesh：

Substances：

Year:  2014        PMID： 24439864     DOI： 10.1016/j.ijcard.2013.12.295

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  15 in total

1.  Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty.

Authors:  I-Chih Chen; Chao-Chin Yu; Yi-Hsuan Wu; Ting-Hsing Chao
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

2.  A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease.

Authors:  Jia-Ling Lin; Wei-Kung Tseng; Po-Tseng Lee; Cheng-Han Lee; Shih-Ya Tseng; Po-Wei Chen; Hsien-Yuan Chang; Ting-Hsing Chao
Journal:  J Pers Med       Date:  2022-06-06

Review 3.  Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges.

Authors:  Mark Seow Khoon Chong; Wei Kai Ng; Jerry Kok Yen Chan
Journal:  Stem Cells Transl Med       Date:  2016-03-08       Impact factor: 6.940

Review 4.  Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease.

Authors:  Ting-Hsing Chao; I-Chih Chen; Shi-Ya Tseng; Yi-Heng Li
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

5.  Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease.

Authors:  Salim S Hayek; James MacNamara; Ayman S Tahhan; Mosaab Awad; Adithya Yadalam; Yi-An Ko; Sean Healy; Iraj Hesaroieh; Hina Ahmed; Brandon Gray; Salman S Sher; Nima Ghasemzadeh; Riyaz Patel; Jinhee Kim; Edmund K Waller; Arshed A Quyyumi
Journal:  Circ Res       Date:  2016-06-06       Impact factor: 17.367

6.  Targeted delivery of human iPS-ECs overexpressing IL-8 receptors inhibits neointimal and inflammatory responses to vascular injury in the rat.

Authors:  Samantha Giordano; Xiangmin Zhao; Daisy Xing; Fadi Hage; Suzanne Oparil; John P Cooke; Jieun Lee; Karina H Nakayama; Ngan F Huang; Yiu-Fai Chen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-01-22       Impact factor: 4.733

7.  Cilostazol Improves Proangiogenesis Functions in Human Early Endothelial Progenitor Cells through the Stromal Cell-Derived Factor System and Hybrid Therapy Provides a Synergistic Effect In Vivo.

Authors:  Shih-Ya Tseng; Ting-Hsing Chao; Yi-Heng Li; Chung-Lung Cho
Journal:  Biomed Res Int       Date:  2016-08-09       Impact factor: 3.411

8.  Cilostazol-Loaded Poly(ε-Caprolactone) Electrospun Drug Delivery System for Cardiovascular Applications.

Authors:  Marek Rychter; Anna Baranowska-Korczyc; Bartłomiej Milanowski; Marcin Jarek; Barbara M Maciejewska; Emerson L Coy; Janina Lulek
Journal:  Pharm Res       Date:  2018-01-16       Impact factor: 4.200

9.  Cilostazol for intermittent claudication.

Authors:  Tamara Brown; Rachel B Forster; Marcus Cleanthis; Dimitri P Mikhailidis; Gerard Stansby; Marlene Stewart
Journal:  Cochrane Database Syst Rev       Date:  2021-06-30

10.  Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells.

Authors:  Ting-Hsing Chao; I-Chih Chen; Yi-Heng Li; Po-Tseng Lee; Shih-Ya Tseng
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.